How to Help Your Patients Save Money on Lokelma: A Provider's Guide to Savings Programs

At approximately $1,000–$1,043 per month retail, Lokelma (sodium zirconium cyclosilicate) carries a list price that, without assistance, would be unaffordable for many patients. High out-of-pocket costs are a primary driver of prescription abandonment and medication non-adherence—which in the context of hyperkalemia management means patients discontinuing life-sustaining RAAS inhibitors.

As a prescriber, being proactive about Lokelma cost management at the point of prescribing—not after a patient calls in frustrated from the pharmacy—dramatically improves the likelihood your patients will actually start and stay on treatment. This guide consolidates everything you need to know about available savings programs in 2026.

The Lokelma Cost Problem in Practice

For context, here are the cost scenarios your patients face:

• Uninsured/cash pay: ~$1,027–$1,043 retail per month; GoodRx brings this to ~$869; AstraZeneca card covers up to $250
• Commercially insured: Typically Tier 3 specialty; copay varies widely but can be $100–$500+/month without assistance; AstraZeneca savings card brings it to as low as $0 (max $450 savings/fill)
• Medicare Part D: Covered on most plans; prior auth required; $2,100 annual OOP cap (2026) provides protection; AstraZeneca savings card NOT usable with Medicare
• Medicaid: Coverage varies by state; may require step therapy; prior authorization common; AstraZeneca card not applicable

Program 1: AstraZeneca Lokelma Savings Card (Commercially Insured Patients)

The manufacturer's savings card is the most impactful tool for commercially insured patients. Key details:

• Commercially insured patients: Pay as low as $0 per 30-packet supply; maximum savings of $450 per fill; valid for 12 months; renewable
• Cash-paying patients: AstraZeneca covers up to the first $250 per monthly prescription; patient pays remainder
• Enrollment: lokelma.com/savings or call 1-844-565-3562; patients can self-enroll or your office can facilitate
• Not eligible: Medicare, Medicaid, VA/TRICARE, and other federal/state programs; cannot be combined with other offers

Practice tip: Have your staff direct newly prescribed patients to the savings card at the time of prescribing. Many offices keep enrollment cards in the exam room for specialty medications.

Program 2: AZ&Me Prescription Savings Program (Uninsured / Underinsured)

For patients who are uninsured, underinsured, or whose insurance doesn't cover Lokelma, AstraZeneca's AZ&Me program provides the medication at low or no cost. Program details:

• Eligibility: U.S. resident; income requirements apply; may include some Medicare patients who qualify for Limited Income Subsidy (LIS/Extra Help), though LIS recipients accepted into the program are no longer eligible for LIS
• How to apply: Call 1-800-292-6363 or visit azandme.com; provider information and prescription required
• Provider role: Providers typically sign off on the application; your staff may need to complete a portion of the enrollment form

Program 3: Medicare Part D and the $2,100 OOP Cap

For Medicare patients, the ACA's Inflation Reduction Act established a $2,100 annual out-of-pocket cap for Part D medications beginning in 2025, with the 2026 cap at $2,100. For patients on Lokelma and multiple other specialty drugs, this cap provides significant protection.

Additionally, Medicare's Prescription Payment Plan (effective January 2025) allows patients to spread their prescription drug out-of-pocket costs across monthly payments throughout the year, rather than paying large lump sums early in the year.

For Medicare patients struggling with Lokelma costs, encourage them to:

1. Confirm their Part D plan covers Lokelma and ask about the tier and copay
2. Apply for Extra Help / Low Income Subsidy (LIS) if their income qualifies
3. Check the AZ&Me program if they're income-eligible

Program 4: Third-Party PAP Advocacy Services

For patients who struggle to navigate PAP applications themselves, third-party advocacy services exist that handle the paperwork and submission process:

• Prescription Hope: Fixed $70/month service fee; works directly with manufacturers; handles documentation and enrollment
• The Rx Advocates: ~$80/month service fee; patient advocacy and PAP navigation

These services may be particularly valuable for elderly, low-health-literacy, or uninsured patients who find paperwork difficult.

Insurance Strategy: Documenting for Prior Authorization and Step Therapy Overrides

Most commercial and Medicare plans require prior authorization for Lokelma, and many impose step therapy requiring trial of older agents (SPS/Kayexalate) first. Effective PA submissions and step therapy exception requests can dramatically reduce patient cost burden:

• Document the patient's specific RAASi regimen and why maintenance is medically necessary (e.g., heart failure with 35% LVEF; proteinuric diabetic CKD on maximum ACE inhibitor dose)
• Document prior failures with SPS if applicable, or contraindications to SPS (GI motility disorders, prior intestinal adverse events)
• Use AstraZeneca's hub line (1-844-565-3562) for PA navigation, appeal letters, and specialty pharmacy coordination

Helping Patients Locate Lokelma After Cost Is Resolved

Once cost barriers are addressed, patients still need to find a pharmacy that stocks Lokelma. Consider recommending medfinder as a tool to locate nearby pharmacies with Lokelma in stock. medfinder calls pharmacies, checks inventory, and texts patients the results—removing the logistical friction that leads to prescription abandonment even after cost issues are resolved.

Summary: Provider Action Checklist for Lokelma Cost Management

• Commercially insured → AstraZeneca Savings Card ($0 copay possible, max $450/fill)
• Uninsured/underinsured → AZ&Me PAP; income requirements apply
• Medicare → Confirm Part D coverage; $2,100 OOP cap; LIS/Extra Help if eligible
• All patients → Initiate prior authorization at prescribing; route to specialty pharmacy; document for step therapy overrides
• Pharmacy access → Recommend medfinder to locate in-stock pharmacies